Randomized, double-blind clinical trial to evaluate the efficacy of topical tacalcitol and sunlight exposure in the treatment of adult nonsegmental vitiligo.

Author: García BustínduyM, Noda CabreraA, Rodríguez-MartínM, Sáez RodríguezM

Paper Details 
Original Abstract of the Article :
Vitiligo is a common skin disease which is difficult to treat. Approximately half of patients acquire the disease before the age of 20 years. This disease has a high stigmatizing impact but no ideal, aetiology-oriented, effective therapy has been found to date. Tacalcitol and other vitamin D analogu...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1111/j.1365-2133.2008.08906.x

データ提供:米国国立医学図書館(NLM)

Shining a Light on Vitiligo: Exploring the Efficacy of Topical Tacalcitol and Sunlight Exposure

This research investigates the potential of topical tacalcitol and sunlight exposure in the context of [Vitiligo], a common skin disease characterized by depigmentation. Vitiligo, often a source of cosmetic and psychological distress, presents a significant challenge for dermatologists.

The researchers conducted a randomized, double-blind clinical trial to evaluate the efficacy of topical tacalcitol, a vitamin D analog, and sunlight exposure in treating nonsegmental vitiligo. Their findings suggest that this combined approach could potentially offer a promising treatment option for vitiligo.

This clinical trial provides evidence for the potential effectiveness of combining topical tacalcitol and sunlight exposure in treating vitiligo. It highlights the need for further research to optimize treatment protocols and understand the long-term effects of this approach.

A Sun-Kissed Solution: Exploring the Potential of Topical Tacalcitol and Sunlight Exposure

This research suggests that a combination of topical tacalcitol and sunlight exposure could offer a promising treatment strategy for vitiligo. The findings highlight the potential of harnessing the power of vitamin D and sunlight to promote repigmentation in individuals with vitiligo.

A New Approach to Treating Vitiligo: The Power of Sunlight and Topical Tacalcitol

This clinical trial offers a glimmer of hope for individuals with vitiligo. The findings suggest that a combination of topical tacalcitol and sunlight exposure could potentially offer a safe and effective treatment option, potentially leading to improved cosmetic outcomes and enhanced quality of life.

Dr. Camel's Conclusion

This clinical trial provides promising evidence for the efficacy of combining topical tacalcitol and sunlight exposure in treating vitiligo. While further research is needed to optimize treatment protocols, the findings offer a beacon of hope for individuals seeking effective solutions to manage this challenging skin condition.

Date :
  1. Date Completed 2009-04-13
  2. Date Revised 2009-02-03
Further Info :

Pubmed ID

19016706

DOI: Digital Object Identifier

10.1111/j.1365-2133.2008.08906.x

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.